Tumour suppressor p53 helps phagocytes clean up

被引：2
|
作者：
Bordon, Yvonne
机构：
来源：
NATURE REVIEWS IMMUNOLOGY | 2015年 / 15卷 / 09期
关键词：
D O I：
10.1038/nri3900
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Tumour suppressor p53 promotes immune tolerance by clearing apoptotic cells and upregulating immune checkpoint molecules.
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [41] The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome
    Lamprecht, B.
    Kreher, S.
    Moebs, M.
    Sterry, W.
    Doerken, B.
    Janz, M.
    Assaf, C.
    Mathas, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) : 240 - 246
  • [42] P53 tumour suppressor gene and germ cell neoplasia
    Lutzker, SG
    APMIS, 1998, 106 (01) : 85 - 89
  • [43] Epitope analysis of the murine p53 tumour suppressor protein
    Lane, DP
    Stephen, CW
    Midgley, CA
    Sparks, A
    Hupp, TR
    Daniels, DA
    Greaves, R
    Reid, A
    Vojtesek, B
    Picksley, SM
    ONCOGENE, 1996, 12 (11) : 2461 - 2466
  • [44] Is tumour suppressor gene p53 involved in neuroendocrine tumour carcinogenesis? Reply
    Wang, DG
    Johnston, CF
    JOURNAL OF PATHOLOGY, 1996, 178 (03): : 360 - 360
  • [45] The human p53 gene encodes nine p53 protein isoforms that can modulate p53 tumour suppressor activity.
    Bourdon, JCR
    Murray-Zmijewski, F
    McDowell, H
    Thompson, A
    Lane, DP
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S185 - S185
  • [46] p19ARF links the tumour suppressor p53 to Ras
    Ignacio Palmero
    Cristina Pantoja
    Manuel Serrano
    Nature, 1998, 395 : 125 - 126
  • [47] p19ARF links the tumour suppressor p53 to Ras
    Nature, 6698 (125):
  • [48] p19ARF links the tumour suppressor p53 to Ras
    Palmero, I
    Pantoja, C
    Serrano, M
    NATURE, 1998, 395 (6698) : 125 - 126
  • [49] D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
    M Aoubala
    Breast Cancer Research, 10 (Suppl 2)
  • [50] The role of the p53 tumour suppressor gene in human breast cancer
    Phillips, HA
    CLINICAL ONCOLOGY, 1999, 11 (03) : 148 - 155
12345